Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Chin currently holds 6,212 shares of Harpoon Therapeutics, Inc. (HARP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Chin has been a net buyer of HARP stock. They have purchased $26.7M and sold $11.0M worth of shares.
Mark Chin's most recent insider trade was on Jun 18, 2026, when they sold 6,212 shares at $0.00 per share.
Mark Chin serves as Executive at Harpoon Therapeutics, Inc. (HARP). They have executed 40 insider transactions totaling $37.7M over their tenure at the company.
Mark Chin holds the position of Executive at Harpoon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Mark Chin has shown a buying trading pattern, with $26.7M in total purchases and $11.0M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark Chin was on Jul 16, 2021, when they purchased $8.0M worth of IMRA shares. This transaction involved 1,333,333 shares at $6.00 per share.
Mark Chin currently owns 6,212 shares of Harpoon Therapeutics, Inc. (HARP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Chin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Chin has 40 Form 4 filings on record as an insider at Harpoon Therapeutics, Inc..
Set alerts for Mark Chin and 40,000+ other insiders.